Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 2020

View Archived Issues

Endothelial cells have functional deficits in progeria

More enhancers suggest more pathogenicity: study

Tarsius opens two phase I/II trials of TRS-01 eye drops

Positive preclinical data presented for QPG-1029

Phase II data for arimoclomol as treatment of sporadic inclusion body myositis

Immunitor presents interim phase III data for hepcortespenlisimut-L in HCC

FASN as a new prognostic biomarker in Wilms' tumor

G-721-0282, novel CHI3L1 ligand with anti-proliferative effects in models of osteosarcoma

Chinese researchers patent PI3K inhibitors

Novartis identifies new NLRP3 inflammasome inhibitors

Japanese investigators synthesize new PTPN11 inhibitors

Hanmi Science describes new FLT3 and/or FLT3 ITD mutant inhibitors

New SNF2L2 inhibitors presented by Epizyme

ApoE, largest genetic risk factor for AD, also affects synucleinopathies

11 potential blockbuster drugs offer hope, threaten budgets

Tumor-targeted siRNA/pDNA dual delivery system reprograms the tumor microenvironment

Paraoxonase 1 gene therapy offers long-term protection against lethal doses of nerve agents in mice

Mucolipin-1 found to be a potential therapeutic target for DMD

Amgen studies AMG-509 in phase I for metastatic CRPC

PsiOxus initiates phase I study of NG-641 in metastatic or advanced epithelial tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...